Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice.
about
Is a multivalent hand, foot, and mouth disease vaccine feasible?Enterovirus 71 infection and vaccines.Animal models of enterovirus 71 infection: applications and limitations.Immunogenicity studies of bivalent inactivated virions of EV71/CVA16 formulated with submicron emulsion systems.Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth diseaseUpdate of enterovirus 71 infection: epidemiology, pathogenesis and vaccine.Understanding Enterovirus 71 Neuropathogenesis and Its Impact on Other Neurotropic Enteroviruses.Coxsackievirus A16 infection stimulates imbalances of T cells in children.A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge
P2860
Q27010349-8CD1B450-C682-44FF-8C88-A36493A7AB86Q30238518-2D08F616-2C3F-4178-A554-C43DB7E02607Q33579809-43493EC2-0488-4CFB-9F9A-9B7E8002A671Q33809953-9475BC59-6AFA-43FA-991F-6443408B198CQ35345853-1B7A1E40-D65E-4236-87D0-BF4555BD1781Q38192021-D1FF0C2C-D1FE-43E7-8BB7-E165EBF978A9Q38567118-AC996EE9-D0FD-49DC-A889-67FE7C1E47FAQ38988951-842E96CF-EA07-4EB1-A882-0699C4AF943AQ56787248-4F8F8F64-5E06-4718-BFAD-E53C1970B32F
P2860
Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Protective efficacy of VP1-spe ...... human SCARB2-transgenic mice.
@ast
Protective efficacy of VP1-spe ...... human SCARB2-transgenic mice.
@en
Protective efficacy of VP1-spe ...... human SCARB2-transgenic mice.
@nl
type
label
Protective efficacy of VP1-spe ...... human SCARB2-transgenic mice.
@ast
Protective efficacy of VP1-spe ...... human SCARB2-transgenic mice.
@en
Protective efficacy of VP1-spe ...... human SCARB2-transgenic mice.
@nl
prefLabel
Protective efficacy of VP1-spe ...... human SCARB2-transgenic mice.
@ast
Protective efficacy of VP1-spe ...... human SCARB2-transgenic mice.
@en
Protective efficacy of VP1-spe ...... human SCARB2-transgenic mice.
@nl
P2093
P2860
P1433
P1476
Protective efficacy of VP1-spe ...... human SCARB2-transgenic mice.
@en
P2093
Charles Sia
Hsiao-Yun Shao
Hsuen-Wen Chang
Hui-Min Ho
Min-Han Lin
Pele Chong
Yen-Hung Chow
Yi-Wen Lin
P2860
P304
P356
10.1371/JOURNAL.PONE.0069858
P407
P577
2013-07-30T00:00:00Z